Exit Completed: company sold its business/assets or its part of the business to a local partner and leaved the market or liquidated local entity(ies)
Exited Exit Completed
Krewel Meuselbach GmbH is a German, owner-operated pharmaceutical company known for producing high-quality herbal medicines (phyto-pharmaceuticals) and conventional drugs, manufacturing in Germany (Eitorf & Gehren) for global markets, specializing in liquid/solid forms like syrups and tablets, and offering contract manufacturing. Established from the merger of Krewel Werke (est. 1893) and Meuselbach, they focus on holistic therapy with herbal alternatives and modern pharmaceutical development, serving customers in over 20 countries.
Exit Completed: company sold its business/assets or its part of the business to a local partner and leaved the market or liquidated local entity(ies)
Exited Exit CompletedReceived revenues in Russia in 2022-2024. Revenue decreased in 2024 vs 2023 by more than -10%. 25.11.2025: Dr. Theiss Naturvaren GmbH becomes the new founder of KREVEL MEUSELBACH LLC. KREVEL MEUSELBACH GmbH has been removed from the Unified State Register of Legal Entities.